View This Report »
Get Industry Insights. Simply.
Talk to Amrita
+1 718 303 2019
An absence of head-to-head trials, along with biosimilar launches, provide payers with leverage to demand favorable pricing for branded products in exchange for formulary access. This report addresses ...
Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...
This BCC Research report provides a comprehensive analysis of the renal disease market and its trends from 2016 through 2021. In-depth analysis is provided on predominant treatment of kidney diseases, ...